| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2810 | N-Methylnaltrindole |
2810.0005: 5 mg per vial 2810.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Reference standard for N1′([11C]Methyl)-naltrindole
Highly selective antagonist for δ opioid receptors |
||
| Molar Mass: 428.52 | ||
| C27H28N2O3 | ||
| [111555-57-8] | ||
| Yellowish solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: 4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a (9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-14-methyl-, (4bS,8R,8aS,14bR)- |
||
|
Synonymes: MeNTI; 4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a (9H)-diol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-14-methyl-, [8R- (4bS, 8.alpha., 8a.beta., 14b.beta.)]; (5R,9R,13S,14S)-17-(cyclopropylmethyl)-6,7-dehydro-4,5.alpha.-epoxy-3,14-dihydroxy-N1′-methyl-6,7,2′,3′-indolomorphinan |
||
|
Literature: 1. Madar I. et al. Imaging of δ- and μ-Opioid Receptors in Temporal Lobe Epilepsy by Positron Emission Tomography. Annals of Neurology 1997, 41, 358-367. |
||
| 2. Lever J.R. et al. Synthesis of N1′-([11C]methyl)naltrindole ([11C]MeNTI): A radioligand for positron emission tomographic studies of δ opioid receptors. J. Labelled Compd. Radiopharm. 1995, 36, 137-145. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1